Overview

Mirena in Idiopathic Menorrhagia

Status:
Completed
Trial end date:
2008-11-01
Target enrollment:
Participant gender:
Summary
This is an open-label, uncontrolled, multi-centre observational study that analyses a follow-up of 1600 women with dysfunctional uterine bleeding (idiopathic menorrhagia) over a period of one year.The patients evaluated at four visits, beginning with the insertion visit and 3, 6 and 12 months after insertion.
Details
Lead Sponsor:
Bayer
Treatments:
Levonorgestrel